Skye Bioscience, Inc. Quarterly Depreciation in USD from Q4 2012 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Skye Bioscience, Inc. annual/quarterly Depreciation history and growth rate from Q4 2012 to Q1 2024.
  • Skye Bioscience, Inc. Depreciation for the quarter ending March 31, 2024 was $27.6K, a 16.9% decline year-over-year.
  • Skye Bioscience, Inc. annual Depreciation for 2024 was $204K, a 308% increase from 2023.
  • Skye Bioscience, Inc. annual Depreciation for 2023 was $49.9K, a 56.6% decline from 2022.
  • Skye Bioscience, Inc. annual Depreciation for 2022 was $115K, a 237% increase from 2021.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $27.6K -$5.61K -16.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q1 2023 $33.2K +$6.2K +23% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q1 2022 $27K +$26K +2776% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q1 2021 $938 +$573 +157% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q1 2020 $365 -$1 -0.27% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q1 2019 $366 +$35.00 +10.6% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q1 2018 $331 -$2.1K -86.4% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q1 2017 $2.43K -$1.27K -34.4% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q1 2016 $3.7K +$1.39K +60% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-12
Q1 2015 $2.31K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-13
Q4 2013 $2.37K +$1.58K +200% Nov 1, 2013 Jan 31, 2014 10-Q 2014-03-17
Q4 2012 $791 Nov 1, 2012 Jan 31, 2013 10-Q 2014-03-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.